logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
陈

陈珍萍 (Zhenping Chen)

National Center for Children's Health
H指数:32
被引数:2,869

个人简介

任职于苏州科技大学电子与信息工程学院，副教授。2017年被列为苏州科技大学优秀青年学术带头人培养对象。2016年博士毕业于安徽理工大学。2002年至2016年任教于安徽理工大学电气与信息工程学院。

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Analysis of causes and outcomes of principal secondary thrombotic microangiopathy: a 9-year cohort study from a tertiary pediatric center in China

中国某三级儿科中心9年队列研究对原发性继发性血栓性微血管病的原因和结果分析

Research and Practice in Thrombosis and Haemostasis
IF3.4
2026-08-011
OAAI
Wu, Dan; Zheng, Jie; Yang, Jun; Wang, Bin; Zhu, Guanghua; Chen, Zhi; Sun, Qiang; Zhou, Nan; Chen, Zhenping; Luo, Yanhui; Yang, Wei; Tian, Xiaoyu; Zhang, Hejia; Liu, Xue; Lei, Lei; Tian, Na; Zhang, Kaige; Fang, Li; Mi, Lan; Wei, Ang; Liang, Ying; Qin, Maoquan; Liu, Xiaorong; Jia, Chenguang
The Chinese Haemophilia Individualized Prophylaxis (CHIPS): A cost-effective regimen for zero joint bleeding and long-term joint health in boys with Severe Haemophilia A (SHA) on factor replacement

中国血友病个体化预防（CHIPS）：一种针对严重A型血友病（SHA）男孩接受因子替代治疗实现零关节出血和长期关节健康的成本效益方案

Thrombosis Research
IF3.4
2025-11-010
PRE
Wanru Yao; Di Ai; Qing Zhang; Xiaojing Li; Min Zhou; Ningning Zhang; Yan Wang; Sheng Yang; Zhenping Chen; Gang Li; Koon-Hung Luke; Runhui Wu
Rituximab-first versus eltrombopag monotherapy in pediatric persistent/chronic immune refractory thrombocytopenia after first-line therapy: a prospective multicenter cohort study

利妥昔单抗优先与艾曲波帕单药治疗在儿童持续性/慢性免疫性难治性血小板减少症一线治疗后的比较：一项前瞻性多中心队列研究

Research and Practice in Thrombosis and Haemostasis
IF3.4
2025-10-300
OAAI
Jingyao Ma; Zhifa Wang; Juntao Ouyang; Zheyan Lin; Lingling Fu; Zhenping Chen; Yan Liu; Lijuan Wang; Xi Lin; Xiaoling Cheng; Yu Hu; Shuyue Dong; Jinxi Meng; Jie Ma; Runhui Wu
Outcomes of immune tolerance induction with rituximab to eradicate high-titer inhibitor of hemophilia A: depicted by exponential decay model and the gene expression profile of different outcomes by RNA-sequencing

利妥昔单抗诱导免疫耐受以消除高滴度血友病A抑制物的效果：通过指数衰减模型描述，并采用RNA测序分析不同结局的基因表达谱

Journal of Thrombosis and Haemostasis
IF5
2025-04-240
PRE
Zekun Li; Yongqiang Tang; Zhenping Chen; Guoqing Liu; Wanru Yao; Gang Li; Xiaoling Cheng; Yaguang Peng; Siyu Cai; Chang Cui; Di Ai; Jialu Zhang; Man−Chiu Poon; Wensheng Zhang; Runhui Wu
Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial

中剂量免疫耐受诱导方案相较于低剂量方案，具有更快的达标速度、更少的出血事件且不增加医疗成本：一项多中心随机对照临床试验

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS
IF3.4
2025-01-010
OAAI
Li, Zhengping; Li, Zekun; Cheng, Xiaoling; Zhang, Heng; Yang, Can; Xu, Qian; Chen, Zhenping; Zhen, Yingzi; Li, Gang; Liu, Guoqing; Yao, Wanru; Zhou, Min; Jin, Jiao; Huang, Jie; Fang, Yongjun; Xie, Liangzhi; Poon, Man-Chiu; Wu, Runhui

研究方向

主要研究控制理论在电能质量检测与识别中的应用
R
Runhui Wu
H 指数:20论文数:257被引数:1,904
H 指数:0论文数:52被引数:0
X
Xiaoling Cheng
H 指数:17论文数:109被引数:995
刘
刘国庆
H 指数:38论文数:461被引数:5,741
K
Kun Huang
H 指数:9论文数:64被引数:229
G
Gang Li
H 指数:15论文数:142被引数:786
W
Wanru Yao
H 指数:5论文数:31被引数:81
Z
Zekun Li
H 指数:13论文数:68被引数:457
J
Jingyao Ma
H 指数:10论文数:66被引数:305
D
Di Ai
H 指数:6论文数:22被引数:125